EAST WINDSOR, N.J. — Aurobindo Pharma announced that digoxin tablets in 0.62mg strength has been approved by the FDA and is now available. The company also said that this is the first and only generic in the marketplace for this product.
EAST WINDSOR, N.J. – Aurobindo Pharma has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application digoxin tablets USP, 0.0625 mg, 0.125 mg and 0.25 mg. Aurobindo Pharma’s digoxin tablets, are an AB-rated generic equivalent to the reference listed drug (RLD), Lanoxin Tablets USP, of Concordia Pharmaceuticals. Digoxin tablets
